Advertisement

New morphological changes induced by FK506 in a short period in the rat kidney and the effect of superoxide dismutase and OKY-046 on THEM: the relationship of FK506 nephrotoxicity to lipid peroxidation and change in production of thromboxane A2 in the kidney

  • K. Yamada
  • Y. Sugisaki
  • S. Suzuki
  • M. Akimoto
  • H. Amemiya
  • N. Yamanaka
Conference paper

Abstract

Juxtaglomerular (JG) hyperplasia and tubular damage along with a decrease in the urine creatinine level induced by FK506 in rat kidney have already been reported in previous paper by us [6]. In this paper, we document the relationship of FK506 nephrotoxicity to the change in the production of thromboxane (Tx) A2 and the lipid peroxidation of the cellular membrane in the rat kidney in order to clarify its morphogenesis. The urinary excretion of TxB2 increased with FK506 administration even on. day 1 (P < 0.02). Histologically, OKY-046 (thromboxane synthetase inhibitor) decreased tubular damage, although JG hyperplasia was not eradicated, while biochemically the excretion of TxB2 decreased significantly (P < 0.02), and both the decrease in the urine creatinine level and the increase in the N-acetyl-β,D-glucosamini-dase (NAG) index were relatively smaller. Although the FK506-induced morphological and biochemical changes could not be prevented by the continuous administration of superoxide dismutase (SOD) 30000 U/kg daily, the malondialdehyde content in renal tissue removed 1 h after FK506 administration had increased. These data suggest that FK506 nephrotoxicity is related to the change in the production of TxA2 and lipid peroxidation of the cellular membrane. However, other mechanisms such as the involvement of sympathomimetic effects of FK506 and other vasoconstrictive factors cannot be rules out.

Key words

FK506 Nephrotoxicity JG hyperplasia Thromboxane Tubular damage Vasoconstriction 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goto T, Kino T, Hatanaka H, Nishiyama M, Okuhara M, Kohsaka M, Aoki H, Imanaka H (1987) Discovery of FK506, a novel immunosuppressant isolated from Streptomyces tsukabaensis. Transplant Proc 19 [Suppl 6]: 4–8PubMedGoogle Scholar
  2. 2.
    Ochiai T, Sakamoto K, Nagata M, Nakajima K, Goto T, Hori S, Kenmochi T, Nakagori T, Asano T, Isono K (1988) Studies on FK506 in experimental organ transplantation. Transplant Proc 20 [Suppl 1]: 209–214PubMedGoogle Scholar
  3. 3.
    Starzl T, Todo S, Fung J, Demetris A, Venkataramman R, Jain A (1989) FK506 for liver, kidney and pancreas transplantation. Lancet 2: 1000–1004PubMedCrossRefGoogle Scholar
  4. 4.
    Ochiai T, Sakamoto K, Gunji Y, Hamaguchi K, Isegawa N, Suzuki T, Shimada H, Hayashi H, Yasumoto A, Asano T, Isono K (1989) Effect of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dog. Transplantation 48:193–197PubMedCrossRefGoogle Scholar
  5. 5.
    Kumano K, Wang G, Endo T, Kuwao S (1991) FK506 induced nephrotoxicity in rats. Transplant Proc 23:512–515PubMedGoogle Scholar
  6. 6.
    Yamada K, Sugisaki Y, Akimoto M, Yamanaka N (1991) Short term FK506 induced morphological changes in rat kidney. Transplant Proc (in press)Google Scholar
  7. 7.
    Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G (1988) Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporine A nephrotoxicity. Kidney Int 34:164–174PubMedCrossRefGoogle Scholar
  8. 8.
    Petric R, Freeman D, Wallace C (1988) Effect of cyclosporine on urinary prostanoid excretion, renal blood flow, and glomerulo-tubular function. Transplantation 45:883PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • K. Yamada
    • 1
  • Y. Sugisaki
    • 1
  • S. Suzuki
    • 3
  • M. Akimoto
    • 2
  • H. Amemiya
    • 3
  • N. Yamanaka
    • 1
  1. 1.Departments of Pathology, Nippon Medical SchoolNational Cardiovascular CenterOsakaJapan
  2. 2.Departments of Urology, Nippon Medical SchoolNational Cardiovascular CenterOsakaJapan
  3. 3.Department of Surgical ResearchNational Cardiovascular CenterOsakaJapan

Personalised recommendations